.png)
Coronary atherectomy devices are used to remove plaque from the coronary arteries, helping to restore proper blood flow and improve cardiovascular health. These devices are crucial for treating patients with severe coronary artery disease. In this article, we highlight the top 10 companies leading the coronary atherectomy device market, providing insights into their headquarters, growth rates, and recent revenues.
The latest research study on the global Coronary Atherectomy Devices market finds that the global Coronary Atherectomy Devices market reached a value of USD 247.21 million in 2023. It’s expected that the market will achieve USD 376.99 million by 2030, exhibiting a CAGR of 6.21% during the forecast period.
Global Growth Insights unveils the top Global Coronary Atherectomy Devices Companies:
1. Cardiovascular Systems Inc.
Headquarters: St. Paul, Minnesota, USA
CAGR: 7.1%
Revenue (Past Year): $252 million
Cardiovascular Systems Inc. specializes in the development and commercialization of innovative solutions for treating peripheral and coronary artery disease. Their coronary atherectomy devices are designed to improve patient outcomes and reduce the risk of restenosis.
2. Philips
Headquarters: Amsterdam, Netherlands
CAGR: 6.8%
Revenue (Past Year): $19.5 billion
Philips is a global leader in health technology, offering a wide range of medical devices, including coronary atherectomy devices. Their innovative solutions are designed to enhance the precision and safety of cardiovascular procedures, improving patient care.
3. Boston Scientific
Headquarters: Marlborough, Massachusetts, USA
CAGR: 6.9%
Revenue (Past Year): $11.9 billion
Boston Scientific is a leading provider of medical devices for various interventional procedures, including coronary atherectomy. Their advanced technologies are designed to improve the efficiency and effectiveness of cardiovascular treatments, enhancing patient outcomes.
4. Medtronic
Headquarters: Dublin, Ireland
CAGR: 6.5%
Revenue (Past Year): $30.1 billion
Medtronic is a global leader in medical technology, offering a wide range of innovative solutions for treating cardiovascular diseases. Their coronary atherectomy devices are designed to provide precise and effective plaque removal, improving patient outcomes.
5. Abbott Laboratories
Headquarters: Abbott Park, Illinois, USA
CAGR: 6.7%
Revenue (Past Year): $34.6 billion
Abbott Laboratories is a major player in the medical device industry, providing advanced solutions for cardiovascular health. Their coronary atherectomy devices are designed to improve the safety and efficacy of plaque removal procedures, enhancing patient care.
6. Terumo Corporation
Headquarters: Tokyo, Japan
CAGR: 6.4%
Revenue (Past Year): $6.5 billion
Terumo Corporation is a leading provider of medical devices and solutions, including coronary atherectomy devices. Their innovative products are designed to enhance the precision and safety of cardiovascular procedures, improving patient outcomes.
7. B. Braun Melsungen AG
Headquarters: Melsungen, Germany
CAGR: 6.3%
Revenue (Past Year): $8.3 billion
B. Braun Melsungen AG specializes in providing high-quality medical devices and solutions, including coronary atherectomy devices. Their products are designed to improve the safety and effectiveness of cardiovascular treatments, enhancing patient care.
8. Spectranetics (acquired by Philips)
Headquarters: Colorado Springs, Colorado, USA
CAGR: 6.5%
Revenue (Past Year): $76 million (prior to acquisition)
Spectranetics, now a part of Philips, was known for its advanced laser atherectomy devices for treating cardiovascular diseases. Their innovative technologies are designed to provide precise and effective plaque removal, improving patient outcomes.
9. Cardinal Health
Headquarters: Dublin, Ohio, USA
CAGR: 6.2%
Revenue (Past Year): $152.9 billion
Cardinal Health is a major provider of medical products and solutions, including coronary atherectomy devices. Their innovative products are designed to enhance the safety and efficacy of cardiovascular procedures, improving patient care.
10. AngioDynamics
Headquarters: Latham, New York, USA
CAGR: 6.0%
Revenue (Past Year): $291 million
AngioDynamics specializes in providing innovative medical devices for vascular access, surgery, and peripheral interventions. Their coronary atherectomy devices are designed to improve the precision and effectiveness of plaque removal procedures, enhancing patient outcomes.
Conclusion
The coronary atherectomy device market is crucial for providing effective treatments for patients with severe coronary artery disease. The top 10 companies highlighted in this article are leading the way in developing innovative and high-quality devices that improve patient outcomes and enhance cardiovascular health. As the demand for effective cardiovascular treatments continues to grow, these companies are well-positioned to drive future advancements and set new standards in the industry.